Abstract
The aim of this study was to explore the association between different types of headache (HA) and the clinical features of multiple sclerosis (MS). The relationship between HA and MS-specific therapies was also analysed. A total of 102 MS patients were recruited at the MS Centre of S. Andrea Hospital in Rome. According to International Headache Society criteria, the lifetime prevalence of primary HA was 61.8%. Migraine was observed more often in young relapsing-remitting MS patients, whilst tension-type HA was associated with older age, male gender and a secondary progressive course. Sixty-four patients had a history of ongoing or past interferon beta (IFNb) exposure. Of these, 17 subjects did not have a history of HA, while 24 complained of an increase in frequency of migraine attacks and 7 reported an IFNb-induced HA. Investigating and treating HA in MS patients starting IFNb therapy may improve MS-specific medication compliance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Freedman MS, Gray TA (1989) Vascular headache: a presenting symptom of multiple sclerosis. Can J Neurol Sci 16:63–66
Rolak LA, Brown S (1990) Headaches and multiple sclerosis: a clinical study and review of the literature. J Neurol 237:300–302
Pollmann W, Erasmus LP, Feneberg W et al (2002) Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 59:636–639
D’Amico D, La Mantia L, Rigamonti A et al (2004) Prevalence of primary headaches in people with multiple sclerosis Cephalalgia 24:980–984
Brandes JL (2000) Migraine induced by interferon beta therapy for multiple sclerosis. Neurology 54[Suppl 3]:A422
La Mantia L, D’Amico D, Rigamonti A et al (2006) Interferon treatment may trigger primary headaches in multiple sclerosis patients. Mult Scler 12:476–480
McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis. Ann Neurol 50:121–127
Kurtzke JF (1983) Rating neurological impairment in Multiple Sclerosis. An expanded disability status scale (EDSS). Neurology 33:1444–1452
Headache Classification Subcommittee of the International Headache Society (2004) International Classification of Headache Disorders, 2nd Edn Cephalalgia [Suppl 1]:9–160
Durelli L, Verdun E, Barbero P et al (2002) Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: a results of a 2-year prospective randomised multicentre study (INCOMIN). Lancet 359:1453–1460
Panitch H, Goodin DS, Francis G et al (2002) Randomized, comparative study of interferon beta-1a treatment regimens in MS. The EVIDENCE trial. Neurology 59:1496–1506
Mitsikostas DD, Thomas AM (1999) Comorbidity of headache and depressive disorders. Cephalalgia 19:211–217
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Villani, V., Prosperini, L., Ciuffoli, A. et al. Primary headache and multiple sclerosis: preliminary results of a prospective study. Neurol Sci 29 (Suppl 1), 146–148 (2008). https://doi.org/10.1007/s10072-008-0908-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-008-0908-3